Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

BBIO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 28.52%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $64,577,549.43

BridgeBio Pharma Insider Trading History Chart

BridgeBio Pharma Share Price & Price History

^$30.94

▲ +2.23 (7.77%)

As of 12/1/2023 01:00 AM ET

Days: 30 | 90 | 365

New CBOE “special perk” helps traders target income every weekend

From DTI Trader | Ad

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

BridgeBio Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/17/2023	Brian C. Stephenson	CFO	Sell	22,683	$28.59	$648,506.97	36,710
8/17/2023	Neil Kumar	CEO	Sell	51,552	$28.59	$1,473,871.68	4,813,197
7/18/2023	Global Investors Lp Viking	Major Shareholder	Sell	1,500,000	$35.00	$52,500,000.00	25,120,991
5/17/2023	Brian C. Stephenson	CFO	Sell	24,424	$14.01	$342,180.24	36,408
5/17/2023	Neil Kumar	CEO	Sell	51,552	$14.01	$722,243.52	4,813,197
4/5/2023	Brian C. Stephenson	CFO	Sell	55,500	$15.45	$857,475.00	101,337
4/5/2023	Neil Kumar	CEO	Sell	120,000	$15.46	$1,855,200.00	1,132,722
3/3/2023	Brian C. Stephenson	CFO	Sell	62,692	$10.96	$687,104.32	156,837
3/3/2023	Neil Kumar	CEO	Sell	120,000	$10.96	$1,315,200.00	1,252,722
2/17/2023	Brian C. Stephenson	CFO	Sell	17,717	$12.70	$225,005.90	219,529
2/17/2023	Neil Kumar	CEO	Sell	44,798	$12.70	$568,934.60	4,813,197
2/3/2023	Brian C. Stephenson	CFO	Sell	61,040	$11.01	$672,050.40	219,184
2/3/2023	Neil Kumar	CEO	Sell	120,000	$11.01	$1,321,200.00	1,372,722
1/5/2023	Brian C. Stephenson	CFO	Sell	61,040	$7.67	$468,176.80	280,224
1/5/2023	Neil Kumar	CEO	Sell	120,000	$7.67	$920,400.00	1,492,722
11/17/2022	Brian C. Stephenson	CFO	Sell	19,678	$9.40	$184,973.20	341,264
11/17/2022	Neil Kumar	CEO	Sell	34,640	$9.40	$325,616.00	4,813,197
3/14/2022	Douglas A. Dachille	Director	Buy	10,000	$8.19	$81,900.00
1/4/2022	Douglas A. Dachille	Director	Buy	5,000	$16.82	$84,100.00
12/30/2021	Ronald J. Daniels	Director	Buy	10,402	$14.34	$149,164.68
12/28/2021	Ronald J. Daniels	Director	Buy	11,745	$12.73	$149,513.85
8/4/2021	Richard H. Scheller	Insider	Sell	13,777	$53.23	$733,349.71
2/17/2021	Brian C. Stephenson	Insider	Buy	8,000	$62.50	$500,000.00
2/17/2021	Genetic Disorder L.P. Kkr	Major Shareholder	Sell	3,450,000	$60.47	$208,621,500.00
2/17/2021	Randal W Scott	Director	Buy	16,000	$62.50	$1,000,000.00	21,000
12/28/2020	Cameron Turtle	Insider	Sell	19,500	$69.60	$1,357,200.00	20,068
12/21/2020	Richard H. Scheller	Insider	Sell	60,401	$65.32	$3,945,393.32	91,333
12/1/2020	Michael Thomas Henderson	Insider	Sell	10,000	$51.52	$515,200.00	284,211

New CBOE “special perk” helps traders target income every weekend

From DTI Trader | Ad

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

SEC Filings (Institutional Ownership Changes) for BridgeBio Pharma (NASDAQ:BBIO)

90.85% of BridgeBio Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BridgeBio Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/1/2023	Wellington Management Group LLP	1,419,550	$37.43M	0.0%	N/A	0.816%
11/30/2023	American Century Companies Inc.	308,292	$8.13M	0.0%	+2,671.2%	0.177%
11/17/2023	Diversified Trust Co	17,111	$0.45M	0.0%	+2.5%	0.010%
11/16/2023	Ironwood Investment Management LLC	64,537	$1.70M	1.0%	-2.8%	0.037%
11/16/2023	Tudor Investment Corp Et Al	81,150	$2.14M	0.0%	N/A	0.047%
11/15/2023	The Manufacturers Life Insurance Company	665,604	$17.55M	0.0%	+170.8%	0.383%
11/15/2023	GSA Capital Partners LLP	86,071	$2.27M	0.2%	N/A	0.049%
11/15/2023	Sectoral Asset Management Inc.	180,195	$4.75M	0.9%	N/A	0.104%
11/15/2023	Legal & General Group Plc	92,727	$2.45M	0.0%	-0.8%	0.053%
11/15/2023	Glenmede Trust Co. NA	16,494	$0.44M	0.0%	-17.3%	0.009%
11/15/2023	AQR Capital Management LLC	22,202	$0.59M	0.0%	-14.0%	0.013%
11/14/2023	Eventide Asset Management LLC	716,927	$18.91M	0.3%	-23.8%	0.412%
11/14/2023	Schonfeld Strategic Advisors LLC	167,119	$4.41M	0.0%	N/A	0.096%
11/14/2023	Corton Capital Inc.	8,711	$0.23M	0.1%	-17.4%	0.005%
11/14/2023	Fred Alger Management LLC	131,623	$3.47M	0.0%	N/A	0.076%
11/14/2023	Caxton Associates LP	7,843	$0.21M	0.0%	N/A	0.005%
11/14/2023	Boone Capital Management LLC	313,381	$8.26M	2.6%	N/A	0.180%
11/14/2023	Nomura Holdings Inc.	235,009	$6.20M	0.0%	-34.5%	0.135%
11/14/2023	California State Teachers Retirement System	103,333	$2.73M	0.0%	-10.6%	0.059%
11/14/2023	Tower Research Capital LLC TRC	1,986	$52K	0.0%	-86.0%	0.001%
11/14/2023	Trexquant Investment LP	9,216	$0.24M	0.0%	N/A	0.005%
11/14/2023	Primecap Management Co. CA	938,700	$24.75M	0.0%	+34.9%	0.540%
11/14/2023	Profund Advisors LLC	53,869	$1.42M	0.1%	-43.0%	0.031%
11/13/2023	Covestor Ltd	9,587	$0.25M	0.2%	+131.5%	0.006%
11/13/2023	Algert Global LLC	65,564	$1.73M	0.1%	+64.4%	0.038%
11/13/2023	Northern Trust Corp	1,153,915	$30.43M	0.0%	+2.2%	0.663%
11/13/2023	EAM Investors LLC	88,167	$2.33M	0.4%	-42.9%	0.051%
11/13/2023	Federated Hermes Inc.	465,776	$12.28M	0.0%	+7.3%	0.268%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	5,000	$0.13M	0.0%	N/A	0.003%
11/13/2023	M28 Capital Management LP	121,200	$3.20M	3.7%	-27.1%	0.070%
11/13/2023	Envestnet Asset Management Inc.	29,254	$0.77M	0.0%	+38.2%	0.017%
11/13/2023	Rafferty Asset Management LLC	313,382	$8.26M	0.0%	-39.6%	0.180%
11/13/2023	Lord Abbett & CO. LLC	794,401	$20.95M	0.1%	N/A	0.457%
11/13/2023	E Fund Management Co. Ltd.	16,095	$0.42M	0.0%	-42.3%	0.009%
11/9/2023	Mizuho Markets Americas LLC	80,532	$2.12M	0.1%	-6.8%	0.046%
11/9/2023	Rhumbline Advisers	179,759	$4.74M	0.0%	+1.1%	0.103%
11/9/2023	Tocqueville Asset Management L.P.	14,200	$0.37M	0.0%	-26.2%	0.008%
11/9/2023	Skandinaviska Enskilda Banken AB publ	30,189	$0.80M	0.0%	N/A	0.017%
11/9/2023	UBS Group AG	152,570	$4.02M	0.0%	-12.7%	0.088%
11/8/2023	State of New Jersey Common Pension Fund D	82,184	$2.17M	0.0%	N/A	0.047%
11/8/2023	Campbell & CO Investment Adviser LLC	15,296	$0.40M	0.0%	N/A	0.009%
11/8/2023	HighTower Advisors LLC	199,236	$5.25M	0.0%	-10.9%	0.115%
11/8/2023	Charles Schwab Investment Management Inc.	1,056,275	$27.85M	0.0%	+9.7%	0.607%
11/8/2023	Blueshift Asset Management LLC	16,482	$0.44M	0.3%	N/A	0.009%
11/8/2023	Swiss National Bank	194,100	$5.12M	0.0%	+1.2%	0.112%
11/8/2023	Amalgamated Bank	15,775	$0.42M	0.0%	+3.8%	0.009%
11/8/2023	Moody Aldrich Partners LLC	137,512	$3.63M	0.7%	+72.2%	0.079%
11/8/2023	New York Life Investment Management LLC	21,440	$0.57M	0.0%	-13.7%	0.012%
11/7/2023	Virtus ETF Advisers LLC	18,018	$0.48M	0.3%	-11.4%	0.010%
11/7/2023	Arizona State Retirement System	25,134	$0.66M	0.0%	+1.6%	0.014%
11/7/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	15,289	$0.40M	0.0%	+4.9%	0.009%
11/6/2023	Assenagon Asset Management S.A.	40,758	$1.08M	0.0%	-73.0%	0.025%
11/6/2023	Los Angeles Capital Management LLC	15,207	$0.40M	0.0%	-34.9%	0.009%
11/6/2023	Victory Capital Management Inc.	435,413	$11.48M	0.0%	-21.4%	0.268%
11/2/2023	Principal Financial Group Inc.	745,666	$19.66M	0.0%	+1,744.9%	0.459%
11/2/2023	Duality Advisers LP	49,156	$1.30M	0.2%	N/A	0.030%
11/2/2023	Nisa Investment Advisors LLC	43,420	$1.15M	0.0%	-14.6%	0.027%
10/31/2023	Teacher Retirement System of Texas	25,068	$0.66M	0.0%	+4.9%	0.015%
10/31/2023	Panagora Asset Management Inc.	176,544	$4.66M	0.0%	+25.9%	0.109%
10/31/2023	Jennison Associates LLC	20,301	$0.54M	0.0%	-62.3%	0.012%
10/31/2023	China Universal Asset Management Co. Ltd.	4,171	$0.11M	0.0%	+98.2%	0.003%
10/27/2023	Hennion & Walsh Asset Management Inc.	87,981	$2.32M	0.1%	+4.1%	0.054%
10/27/2023	Assetmark Inc.	1,996	$53K	0.0%	N/A	0.001%
10/27/2023	Emerald Mutual Fund Advisers Trust	500,254	$13.19M	0.8%	+26.5%	0.308%
10/26/2023	Emerald Advisers LLC	694,000	$18.30M	0.9%	+44.8%	0.427%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	64,869	$1.71M	0.0%	-5.1%	0.040%
10/26/2023	Strs Ohio	6,900	$0.18M	0.0%	N/A	0.004%
10/19/2023	Handelsbanken Fonder AB	24,750	$0.65M	0.0%	+4.2%	0.015%
10/11/2023	Vontobel Holding Ltd.	66,357	$1.75M	0.0%	-1.8%	0.041%
10/10/2023	WCM Investment Management LLC	284,487	$7.50M	0.0%	+2.1%	0.175%
9/21/2023	Baystate Wealth Management LLC	14,750	$0.25M	0.0%	N/A	0.009%
9/21/2023	Barclays PLC	589,164	$10.13M	0.0%	-12.5%	0.363%
8/24/2023	Perceptive Advisors LLC	1,748,933	$30.08M	0.9%	-8.3%	1.076%
8/21/2023	California State Teachers Retirement System	115,626	$1.99M	0.0%	+17.4%	0.071%
8/15/2023	Alliancebernstein L.P.	155,591	$2.68M	0.0%	+17.2%	0.096%
8/15/2023	Vestcor Inc	73,849	$1.27M	0.0%	N/A	0.045%
8/15/2023	Clearline Capital LP	262,920	$4.52M	0.3%	-0.8%	0.162%
8/15/2023	Woodline Partners LP	290,000	$4.99M	0.1%	-7.4%	0.178%
8/15/2023	XTX Topco Ltd	20,248	$0.35M	0.1%	N/A	0.012%
8/15/2023	Captrust Financial Advisors	19,425	$0.33M	0.0%	N/A	0.012%
8/15/2023	Point72 Asset Management L.P.	66,674	$1.15M	0.0%	+3.9%	0.041%
8/15/2023	Rockefeller Capital Management L.P.	58,470	$1.01M	0.0%	+18.8%	0.036%
8/15/2023	Silverarc Capital Management LLC	50,000	$0.86M	0.3%	+25.0%	0.031%
8/14/2023	Mercer Global Advisors Inc. ADV	14,113	$0.24M	0.0%	+34.4%	0.009%
8/14/2023	State of Wyoming	7,152	$0.12M	0.0%	N/A	0.004%
8/14/2023	Tower Research Capital LLC TRC	14,159	$0.24M	0.0%	+222.7%	0.009%
8/14/2023	State of Wisconsin Investment Board	103,346	$1.78M	0.0%	+66.5%	0.064%
8/14/2023	Bellevue Group AG	96,900	$1.67M	0.0%	+17.3%	0.060%
8/14/2023	Prelude Capital Management LLC	19,041	$0.33M	0.0%	+24.6%	0.012%
8/11/2023	PEAK6 Investments LLC	10,000	$0.17M	0.0%	N/A	0.006%
8/11/2023	Natixis	6,000	$0.10M	0.0%	-60.0%	0.004%
8/11/2023	Ameritas Investment Partners Inc.	9,457	$0.16M	0.0%	+15.3%	0.006%
8/11/2023	Panagora Asset Management Inc.	140,245	$2.41M	0.0%	N/A	0.086%
8/11/2023	M28 Capital Management LP	166,200	$2.86M	3.8%	-45.5%	0.102%
8/11/2023	B. Metzler seel. Sohn & Co. AG	81,556	$1.40M	0.0%	+52.1%	0.050%
8/11/2023	State Board of Administration of Florida Retirement System	32,513	$0.56M	0.0%	-8.6%	0.020%
8/11/2023	The Manufacturers Life Insurance Company	245,791	$4.23M	0.0%	+454.7%	0.151%
8/11/2023	Geode Capital Management LLC	2,419,370	$41.61M	0.0%	+7.4%	1.489%
8/11/2023	Covestor Ltd	4,141	$71K	0.1%	+22,905.6%	0.003%
8/11/2023	E Fund Management Co. Ltd.	27,916	$0.48M	0.0%	+83.5%	0.017%

Data available starting January 2016

BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabilizer of transthyretin, or TTR that is in Phase 3 clinical trial for the treatment of TTR amyloidosis-cardiomyopathy, or ATTR-CM; BBP-831, a small molecule selective FGFR1-3 inhibitor, which is Phase 2 clinical trial to treat achondroplasia in pediatric patients; and BBP-631, an AAV5 gene transfer product candidate that is in Phase 2 clinical trial for the treatment of congenital adrenal hyperplasia, or CAH, driven by 21-hydroxylase deficiency, or 21OHD. The company also develops Encaleret, a small molecule antagonist of the calcium sensing receptor, or CaSR, which is in phase 2 proof-of-concept clinical trial for Autosomal Dominant Hypocalcemia Type 1, or ADH1; and BBP-711 for the treatment of hyperoxaluria, as well as patients suffering from recurrent kidney stones. In addition, it engages in developing products for Mendelian, oncology, and gene therapy diseases. BridgeBio Pharma, Inc. has license and collaboration agreements with the Leland Stanford Junior University; and The Regents of the University of California; Leidos Biomedical Research, Inc. The company was founded in 2015 and is headquartered in Palo Alto, California.

Today's Range

Now: $30.94

$27.74

$30.98

50 Day Range

MA: $27.03

$24.02

$30.94

52 Week Range

Now: $30.94

$6.64

$36.36

Volume

1,428,786 shs

Average Volume

2,412,113 shs

Market Capitalization

$5.38 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

Who are the company insiders with the largest holdings of BridgeBio Pharma?: BridgeBio Pharma's top insider investors include:
Global Investors Lp Viking (Major Shareholder)
Neil Kumar (CEO)
Brian C Stephenson (CFO)
Douglas A Dachille (Director)
Ronald J Daniels (Director)
Learn More about top insider investors at BridgeBio Pharma.
Who are the major institutional investors of BridgeBio Pharma?: BridgeBio Pharma's top institutional investors include:
Wellington Management Group LLP — 0.82%
Northern Trust Corp — 0.66%
Charles Schwab Investment Management Inc. — 0.61%
Primecap Management Co. CA — 0.54%
Portman Square Capital LLP — 0.00%
Lord Abbett & CO. LLC — 0.46%
Learn More about top institutional investors of BridgeBio Pharma stock.
Which institutional investors are selling BridgeBio Pharma stock?: Within the previous quarter, BBIO stock was sold by these institutional investors:
HAP Trading LLC
Kingdon Capital Management L.L.C.
Eventide Asset Management LLC
Rafferty Asset Management LLC
Nomura Holdings Inc.
Victory Capital Management Inc.
Assenagon Asset Management S.A.
Walleye Capital LLC
Within the previous year, company insiders that have sold BridgeBio Pharma company stock include:
Global Investors Lp Viking (Major Shareholder)
Neil Kumar (CEO)
Brian C Stephenson (CFO)
Learn More investors selling BridgeBio Pharma stock.
Which institutional investors are buying BridgeBio Pharma stock?: During the last quarter, BBIO stock was purchased by institutional investors including:
Wellington Management Group LLP
Portman Square Capital LLP
Lord Abbett & CO. LLC
Principal Financial Group Inc.
The Manufacturers Life Insurance Company
Boone Capital Management LLC
American Century Companies Inc.
Primecap Management Co. CA
In the previous year, these company insiders have bought BridgeBio Pharma stock:
Global Investors Lp Viking (Major Shareholder)
Neil Kumar (CEO)
Learn More investors buying BridgeBio Pharma stock.